Image

Bacterial Diversity Study Using 16S rRNA Sequencing of Periodontal Samples From Patients With Orthodontic Retainers

Bacterial Diversity Study Using 16S rRNA Sequencing of Periodontal Samples From Patients With Orthodontic Retainers

Recruiting
18-40 years
All
Phase N/A

Powered by AI

Overview

After completion of orthodontic treatment, a retention phase is required to prevent relapse of tooth malposition. Fixed retention in the mandibular anterior region is commonly used. This type of retainer is bonded to the lingual surfaces of the canines and incisors and may hinder oral hygiene, thereby promoting bacterial plaque accumulation and gingival inflammation.

Currently, probably due to the increasing use of clear aligner therapy, clear removable Essix-type retainers are becoming more widely used. Since these retainers can be removed by the patient, they may facilitate oral hygiene. However, studies assessing gingival health and the composition of the subgingival microbiota in patients wearing orthodontic retainers remain scarce.

Therefore, the aim of this study will be to assess the composition of the gingival sulcus microbiota and gingival health in patients wearing fixed or removable orthodontic retainers.

Ten adult patients who have completed orthodontic treatment will be recruited and divided into two groups:

  1. Fixed retention group.
  2. Removable retention group.

Periodontal parameters will be assessed, and bacterial plaque samples will be collected from the gingival sulcus at five time points:

T0: Bracket removal and dental scaling appointment. Periodontal parameters will be assessed, and plaque samples will be collected before bracket debonding and dental scaling.

T1: Retainer placement appointment, three days after T0. Periodontal parameters will be assessed, and plaque samples will be collected before retainer placement.

T2: One month after retainer placement.

T3: Three months after retainer placement.

T4: Six months after retainer placement.

Description

The objetives of this study are:

  1. To compare the gingival sulcus microbiota in patients wearing fixed versus removable orthodontic retainers.
  2. To compare periodontal health in patients wearing fixed versus removable orthodontic retainers.

Study design:

Ten adult patients attending the University Dental Clinic who are completing orthodontic treatment with fixed multibracket appliances will be recruited.

The following inclusion criteria will be established: (1) patients aged over 18 years; (2) orthodontic treatment involving both dental arches; (3) permanent dentition with at least 24 teeth; (4) an orthodontic treatment duration of more than 12 months; and (5) treatment using the versatile MBT prescription with a 0.022-inch bracket slot.

The exclusion criteria will be: (1) systemic disease or use of medications that may affect periodontal health; (2) defective dental restorations or active carious lesions; (3) periodontal disease; (4) a plaque index greater than 20% before retainer placement or at any time during the study; (5) use of oral antiseptic agents within the previous six months or during the study period; (6) use of antibiotics within the previous 14 days or during the study period; (7) smoking; (8) pregnancy or breastfeeding; and (9) the presence of open gingival embrasures, crowding, or tooth malposition in the mandibular anterior region after completion of orthodontic treatment.

All patients will receive oral hygiene instructions and will be provided with an oral hygiene kit, which they will be required to use throughout the study.

Patients will be divided into two groups:

  1. Fixed retention group.
  2. Removable retention group.

Patients in Group 1 will receive a fixed retainer consisting of a lingual wire bonded to teeth 33 to 43 according to the FDI tooth-numbering system. The same type of wire and bonding material will be used in all patients.

Patients in Group 2 will receive a clear removable Essix-type retainer. All retainers will be manufactured using the same material and by the same dental technician. Patients will be instructed to wear the removable retainer for 22 hours per day.

Periodontal parameters will be assessed and subgingival bacterial plaque samples will be collected from the gingival sulcus at five time points:

T0: Bracket removal and dental scaling appointment. Periodontal parameters will be assessed and plaque samples will be collected before bracket debonding and dental scaling.

T1: Retainer placement appointment, three days after T0. Periodontal parameters will be assessed and plaque samples will be collected before retainer placement.

T2: One month after retainer placement.

T3: Three months after retainer placement.

T4: Six months after retainer placement.

The following clinical parameters will be evaluated:

  1. Plaque index: recorded as the percentage of all examined tooth surfaces presenting plaque. Six surfaces per tooth will be examined: three buccal surfaces and three lingual surfaces.
  2. Bleeding index: recorded as the percentage of all examined tooth surfaces presenting bleeding on probing. Six surfaces per tooth will be examined: three buccal surfaces and three lingual surfaces.
  3. Probing pocket depth: measured from the gingival margin to the base of the periodontal pocket.
  4. Clinical attachment level: measured from the cementoenamel junction to the base of the periodontal pocket.
  5. Gingival recession: measured from the cementoenamel junction to the gingival margin when the gingival margin is located apical to the cementoenamel junction.

Subgingival bacterial plaque samples will be collected from the interproximal areas using sterile paper points. A spatula will be used to gently displace the gingival tissue to allow insertion of the paper point into the gingival sulcus without bending it.

Samples will be collected from the mesial surface of each canine and from the mesial and distal surfaces of each incisor. Each paper point will be cut in half, and only the portion used for sample collection will be placed into an Eppendorf tube containing sterile phosphate-buffered saline solution.

The tubes will subsequently be stored at -22 °C until microbiological analysis by 16S rRNA gene sequencing.

All participants will be instructed to refrain from eating, drinking, brushing their teeth, or using mouthwash for at least two hours before bacterial plaque sample collection.

Eligibility

Inclusion Criteria:

  • Treatment involving both dental arches
  • Permanent dentition with at least 24 teeth
  • Treatment duration longer than 12 months
  • Treatment using the Versatile MBT system with a 0.022-inch slot

Exclusion Criteria:

  • Patients with systemic disease or taking medications that may affect periodontal health
  • Inadequate restorations or active carious lesions
  • iodontal disease
  • Plaque index greater than 20% before placement of the retainer or during the study
  • Use of oral antiseptics within the previous 6 months or during the study period
  • Use of antibiotics within the previous 14 days or during the study period
  • Smokers
  • Pregnant or breastfeeding women
  • Presence of open gingival embrasures, crowding, or dental malposition in the mandibular anterior region after orthodontic treatment

Study details
    Fixed Orthodontic Retainer
    Orthodontic Appliances
    Removable
    Orthodontic Appliances
    Adverse Effects
    Gingivitis
    Dental Plaque
    Periodontal Diseases

NCT07718061

Universidad de Murcia

20 October 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.